These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6961761)

  • 1. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
    Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
    Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
    Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
    Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow.
    Lunell NO; Nylund L; Lewander R; Sarby B
    Br J Obstet Gynaecol; 1982 Aug; 89(8):640-4. PubMed ID: 7104255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uteroplacental blood flow in pregnancy hypertension after the administration of a beta-adrenoceptor blocker, pindolol.
    Lunell NO; Nylund L; Lewander R; Sarby B; Wager J
    Gynecol Obstet Invest; 1984; 18(5):269-74. PubMed ID: 6098541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy.
    Lunell NO; Lewander R; Nylund L; Sarby B; Thornström S
    Gynecol Obstet Invest; 1983; 16(5):274-82. PubMed ID: 6642290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of labetalol in pregnancy.
    Riley AJ
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S53-9. PubMed ID: 6169960
    [No Abstract]   [Full Text] [Related]  

  • 9. Single dose of labetalol in hypertensive pregnancy: effects on maternal hemodynamics and uterine and fetal flow velocity waveforms.
    Pirhonen JP; Erkkola RU; Mäkinen JI; Ekblad UU
    J Perinat Med; 1991; 19(3):167-71. PubMed ID: 1748937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uteroplacental blood flow in diabetic pregnancy: measurements with indium 113m and a computer-linked gamma camera.
    Nylund L; Lunell NO; Lewander R; Persson B; Sarby B
    Am J Obstet Gynecol; 1982 Oct; 144(3):298-302. PubMed ID: 7124844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isradipine, a new calcium antagonist: effects on maternal and fetal hemodynamics.
    Lunell NO; Garoff L; Grunewald C; Nisell H; Nylund L; Sarby B; Thornström S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S37-40. PubMed ID: 1720484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy.
    Lindow SW; Davies N; Davey DA; Smith JA
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1276-81. PubMed ID: 3224091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol disposition and concentration-effect relationships during pregnancy.
    Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
    Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.